{"id":"fibrinolytic-therapy","safety":{"commonSideEffects":[{"rate":"5–15","effect":"Bleeding (major and minor)"},{"rate":"0.5–1","effect":"Intracranial hemorrhage"},{"rate":"1–5","effect":"Allergic reaction"},{"rate":"5–10","effect":"Hypotension"},{"rate":"5–10","effect":"Arrhythmia (reperfusion)"}]},"_chembl":{"chemblId":"CHEMBL4298181","moleculeType":"Gene"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fibrinolytic agents (thrombolytics) work by converting the inactive zymogen plasminogen into its active form, plasmin, which then degrades fibrin—the structural protein that holds blood clots together. This enzymatic degradation dissolves existing thrombi and restores perfusion to ischemic tissues. Common fibrinolytic agents include tissue plasminogen activator (tPA), streptokinase, and urokinase.","oneSentence":"Fibrinolytic therapy dissolves blood clots by activating plasminogen to plasmin, which breaks down fibrin and restores blood flow.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:12:34.580Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute myocardial infarction (ST-elevation MI)"},{"name":"Acute ischemic stroke"},{"name":"Pulmonary embolism"},{"name":"Deep vein thrombosis"}]},"trialDetails":[{"nctId":"NCT07452991","phase":"NA","title":"ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE","status":"RECRUITING","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2024-09-10","conditions":"Pulmonary Embolism (PE)","enrollment":300},{"nctId":"NCT07475065","phase":"PHASE2, PHASE3","title":"The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Universitas Sebelas Maret","startDate":"2026-03-01","conditions":"Diabetic Polyneuropathy, Peripheral Nervous System Diseases, Peripheral Neuropathy","enrollment":34},{"nctId":"NCT04521881","phase":"PHASE3","title":"Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults","status":"RECRUITING","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-04-18","conditions":"Traumatic Brain Injury","enrollment":5000},{"nctId":"NCT07467577","phase":"NA","title":"Does Intraperitoneal Washout Further Reduce Pain After Low-Pressure vNOTES Hysterectomy?","status":"NOT_YET_RECRUITING","sponsor":"Erzincan Military Hospital","startDate":"2026-03-09","conditions":"Postoperative Pain, vNOTES","enrollment":94},{"nctId":"NCT07187687","phase":"NA","title":"TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-10-24","conditions":"Intracerebral Hemorrhage","enrollment":750},{"nctId":"NCT06975969","phase":"","title":"Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter","status":"WITHDRAWN","sponsor":"Liquet Medical Inc.","startDate":"2025-09-05","conditions":"Blood Clots, Vascular Disease, Embolism Thrombosis","enrollment":""},{"nctId":"NCT06672081","phase":"NA","title":"Early Catheter-directed Treatment of High Risk Pulmonary Embolism","status":"RECRUITING","sponsor":"Leipzig Heart Science gGmbH","startDate":"2024-12-27","conditions":"Pulmonary Embolism Acute Massive","enrollment":210},{"nctId":"NCT05903417","phase":"NA","title":"Pleural Irrigation With Normal Saline Versus Intrapleural Fibrinolytic","status":"COMPLETED","sponsor":"National University of Malaysia","startDate":"2023-07-10","conditions":"Pleural Infection","enrollment":40},{"nctId":"NCT06241677","phase":"NA","title":"Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-04-15","conditions":"CVA (Cerebrovascular Accident)","enrollment":260},{"nctId":"NCT07424378","phase":"PHASE4","title":"Epoprostenol Plus Conventional Therapy in COld and Frostbite Injury (ECCO)","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-02","conditions":"Frostbite","enrollment":66},{"nctId":"NCT07389460","phase":"PHASE3","title":"Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2026-01-31","conditions":"Acute Ischemic Stroke","enrollment":820},{"nctId":"NCT07374978","phase":"NA","title":"Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-07-01","conditions":"Pulmonary Embolism Subacute Massive, Thrombolytic Therapy","enrollment":100},{"nctId":"NCT06486181","phase":"PHASE4","title":"Second Line Endovascular Treatment in Acute DVT","status":"NOT_YET_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-04-01","conditions":"Deep Venous Thrombosis","enrollment":100},{"nctId":"NCT06887062","phase":"PHASE2","title":"Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2025-03-21","conditions":"Large Vessel Vasculitis, Giant Cell Arteritis (GCA), Takayasu Arteritis","enrollment":60},{"nctId":"NCT00147316","phase":"PHASE3","title":"Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2002-04","conditions":"Cerebral Infarction, Brain Ischemia","enrollment":103},{"nctId":"NCT07241130","phase":"","title":"Using End-Tidal CO₂ to Help Diagnose and Monitor Pulmonary Embolism","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2025-02-01","conditions":"Pulmonary Embolism Acute","enrollment":120},{"nctId":"NCT06912009","phase":"","title":"Duration of Therapeutic Anticoagulation in Patients With Pulmonary Embolism","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2024-11-06","conditions":"Pulmonary Embolism","enrollment":100},{"nctId":"NCT07234630","phase":"","title":"Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by Coagulopathy","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2026-01","conditions":"Hematologic Neoplasms, Solid Tumor Metastatic Cancer Advanced Cancer, Disseminated Intravascular Coagulation","enrollment":150},{"nctId":"NCT05075200","phase":"PHASE2","title":"Tranexamic Acid Dosing for Major Joint Replacement Surgery","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2021-12-14","conditions":"Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip","enrollment":21},{"nctId":"NCT04344860","phase":"PHASE3","title":"Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial","status":"COMPLETED","sponsor":"Nicoletta C Machin","startDate":"2021-06-04","conditions":"Von Willebrand Diseases, Postpartum Hemorrhage","enrollment":20},{"nctId":"NCT03957707","phase":"NA","title":"Sterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2019-01-01","conditions":"Basal Ganglia Haematoma","enrollment":380},{"nctId":"NCT03424460","phase":"NA","title":"Venous Thromboembolism in Myotonic Dystrophy Type 1","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-06-11","conditions":"Myotonic Dystrophy 1","enrollment":130},{"nctId":"NCT07146997","phase":"PHASE3","title":"Evaluating the Combined Effect of Oral Premedications on Inferior Alveolar Nerve Block Effectiveness","status":"COMPLETED","sponsor":"Zahoor khan","startDate":"2023-11-23","conditions":"Symptomatic Irreversible Pulpitis","enrollment":96},{"nctId":"NCT07095361","phase":"PHASE4","title":"Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema","status":"NOT_YET_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-09","conditions":"Pleural Infection Bacterial, Pleural Infections, Pleural Infections and Inflammations","enrollment":270},{"nctId":"NCT06878066","phase":"PHASE3","title":"Thrombolysis in Factor Xa-inhibitors Trial","status":"RECRUITING","sponsor":"Guri Hagberg","startDate":"2025-03-14","conditions":"Stroke, Stroke (in Patients With Atrial Fibrillation), Ischemic Stroke","enrollment":300},{"nctId":"NCT07146360","phase":"PHASE3","title":"Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction","status":"COMPLETED","sponsor":"AO GENERIUM","startDate":"2014-05-25","conditions":"Myocardial Infarction (MI)","enrollment":180},{"nctId":"NCT05630612","phase":"PHASE2","title":"ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Edinburgh","startDate":"2022-12-08","conditions":"ANCA Associated Vasculitis, Cardiovascular Diseases, Kidney Diseases","enrollment":32},{"nctId":"NCT07119021","phase":"PHASE4","title":"Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)","status":"RECRUITING","sponsor":"Ruijun Ji","startDate":"2024-08-01","conditions":"Ischemic Stroke","enrollment":300},{"nctId":"NCT06052969","phase":"NA","title":"Pulse Endovascular ReperFUSION for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Euphrates Vascular, Inc.","startDate":"2023-10-01","conditions":"Acute Ischemic Stroke AIS, Cerebral Arterial Disease","enrollment":8},{"nctId":"NCT05892510","phase":"PHASE2, PHASE3","title":"Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2024-06-01","conditions":"Ischemic Stroke, Acute, Cerebrovascular Disorders, Brain Disorder","enrollment":462},{"nctId":"NCT06414499","phase":"PHASE3","title":"Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-09","conditions":"Minor Ischemic Stroke","enrollment":1386},{"nctId":"NCT04785651","phase":"NA","title":"Evaluation of the Use of Tranexamic Acid in Tibial Osteotomies","status":"TERMINATED","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2021-02-22","conditions":"Monocompartimental Tibiofemoral Osteoarthritis, Osteoarthritis","enrollment":49},{"nctId":"NCT04806373","phase":"PHASE4","title":"Intrapleural Fibrinolytic Therapy to Enhance Chemical Pleurodesis Enhance Chemical Pleurodesis","status":"COMPLETED","sponsor":"Memorial Healthcare System","startDate":"2021-06-15","conditions":"Pleural Effusion","enrollment":27},{"nctId":"NCT03881345","phase":"","title":"Ongoing Registry of Treatment of Venous Thromboembolism","status":"RECRUITING","sponsor":"Medalp Private Surgery Clinic","startDate":"2019-04-01","conditions":"Deep Vein Thrombosis, Thromboses, Venous, Thrombosis Embolism","enrollment":5000},{"nctId":"NCT06183307","phase":"NA","title":"Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia","status":"RECRUITING","sponsor":"Universidade Federal Fluminense","startDate":"2024-08-03","conditions":"Cardiovascular Diseases, Dyslipidemias, Inflammation","enrollment":48},{"nctId":"NCT06434324","phase":"NA","title":"Pleural Space Saline Irrigation in Addition to Standard Intrapleural Thrombolytic Therapy in Empyema/Complicated Parapneumonic Effusion","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-03-29","conditions":"Pleural Infection","enrollment":60},{"nctId":"NCT06660719","phase":"PHASE3","title":"Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care","status":"RECRUITING","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2025-02-14","conditions":"Ischemic Stroke","enrollment":852},{"nctId":"NCT06861374","phase":"NA","title":"Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic Therapy","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2025-05","conditions":"ST-segment Elevation Myocardial Infarction (STEMI)","enrollment":2400},{"nctId":"NCT06115070","phase":"PHASE4","title":"Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Thrombosis, Acute Ischemic Stroke (AIS)","enrollment":390},{"nctId":"NCT06510634","phase":"","title":"Triage of Patients Presenting Beyond 24 Hours With Ischemic Stroke Due to Vertebrobasilar Artery Occlusion","status":"ENROLLING_BY_INVITATION","sponsor":"Tianjin Huanhu Hospital","startDate":"2019-06-01","conditions":"Stroke, Ischemic","enrollment":236},{"nctId":"NCT06749834","phase":"PHASE3","title":"Intravenous Thrombolysis and NOAC","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-27","conditions":"Acute Ischemic Stroke","enrollment":280},{"nctId":"NCT03167281","phase":"PHASE4","title":"Early Intrapleural TPA Instillation Versus Late","status":"WITHDRAWN","sponsor":"Prisma Health-Midlands","startDate":"2017-02-17","conditions":"Tissue Plasminogen Activator","enrollment":""},{"nctId":"NCT06833827","phase":"NA","title":"'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-02","conditions":"Pulmonary Embolism Acute","enrollment":111},{"nctId":"NCT03186729","phase":"PHASE4","title":"Study of Antithrombotic Treatment After IntraCerebral Haemorrhage","status":"TERMINATED","sponsor":"Oslo University Hospital","startDate":"2018-07-01","conditions":"Cerebral Hemorrhage, Intracranial Hemorrhages, Atrial Fibrillation","enrollment":134},{"nctId":"NCT06812000","phase":"","title":"Post-stroke Seizure and Epilepsy Following Thrombolytic Therapy","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2024-04-14","conditions":"Post-stroke Seizure, Post-stroke Epilepsy, Thrombolytic (t-PA) Treatment","enrollment":199},{"nctId":"NCT04956861","phase":"NA","title":"HIV-1, Insufficient Sleep and Vascular Endothelial Dysfunction","status":"COMPLETED","sponsor":"University of Colorado, Boulder","startDate":"2015-12-17","conditions":"HIV-1","enrollment":88},{"nctId":"NCT06736860","phase":"PHASE4","title":"Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of Thromboelastography","status":"RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2024-08-01","conditions":"Trauma Coagulopathy","enrollment":580},{"nctId":"NCT03876457","phase":"NA","title":"SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2019-10-11","conditions":"Acute Ischemic Stroke","enrollment":352},{"nctId":"NCT06680180","phase":"","title":"Fibrinolysis Resistance in Infection and Trauma","status":"RECRUITING","sponsor":"Anders Aneman","startDate":"2024-06-01","conditions":"Sepsis and Septic Shock, Trauma","enrollment":150},{"nctId":"NCT06667882","phase":"NA","title":"Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests","status":"COMPLETED","sponsor":"Semmelweis University","startDate":"2021-12-17","conditions":"Pulmonary Embolism Subacute Massive, Complication of Treatment, Fibrinolysis; Hemorrhage","enrollment":33},{"nctId":"NCT06587347","phase":"PHASE2, PHASE3","title":"Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Capital Medical University","startDate":"2024-11-20","conditions":"Acute Stroke, Ischemic Stroke, Acute, Cerebral Infarction","enrollment":302},{"nctId":"NCT02777580","phase":"PHASE4","title":"STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction","status":"COMPLETED","sponsor":"KU Leuven","startDate":"2017-08-01","conditions":"Myocardial Infarction","enrollment":609},{"nctId":"NCT03998319","phase":"PHASE3","title":"A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.","status":"RECRUITING","sponsor":"University of Sydney","startDate":"2021-10-14","conditions":"STEMI, Elevated IMR (>32)","enrollment":445},{"nctId":"NCT06487052","phase":"NA","title":"Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients","status":"RECRUITING","sponsor":"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","startDate":"2024-01-10","conditions":"Pulmonary Embolism Acute","enrollment":100},{"nctId":"NCT05735301","phase":"NA","title":"Patient Selection Using MR With Non-Perfusion Imaging for Endovascular Treatment Within 6 to 24 Hours","status":"RECRUITING","sponsor":"Tianjin Huanhu Hospital","startDate":"2019-01-01","conditions":"Endovascular Thrombectomy","enrollment":352},{"nctId":"NCT03012633","phase":"","title":"Rapid Diagnostic of Hyperfibrinolysis in Liver Transplantation","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2017-01-09","conditions":"Liver Transplantation","enrollment":30},{"nctId":"NCT02080520","phase":"NA","title":"Nattokinase Atherothrombotic Prevention Study","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2014-04","conditions":"Prevention of Subclinical Atherosclerosis Progression, Prevention of Cognitive Decline","enrollment":265},{"nctId":"NCT06312852","phase":"","title":"Impact of Antenatal Steroids on Coagulation.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-04-01","conditions":"Corticosteroids Adverse Reaction","enrollment":45},{"nctId":"NCT05601999","phase":"PHASE3","title":"Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction","status":"RECRUITING","sponsor":"AO GENERIUM","startDate":"2021-09-03","conditions":"ST Elevation Myocardial Infarction","enrollment":244},{"nctId":"NCT05586022","phase":"","title":"Risk Factors for Adverse Outcomes of Endovascular Revascularization in Lower Extremity Arteriosclerosis Occlusion","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2022-10-20","conditions":"Peripheral Arterial Occlusive Disease","enrollment":500},{"nctId":"NCT03213834","phase":"PHASE4","title":"Fibrinolytic Therapy Versus Medical Thoracoscopy","status":"COMPLETED","sponsor":"University of Florida","startDate":"2017-09-14","conditions":"Pleural Diseases","enrollment":5},{"nctId":"NCT02604238","phase":"PHASE3","title":"Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism","status":"WITHDRAWN","sponsor":"Azienda U.S.L. 1 di Massa e Carrara","startDate":"2016-03","conditions":"Pulmonary Embolism","enrollment":""},{"nctId":"NCT06234813","phase":"NA","title":"Targeting TFPI With Concizumab to Improve Haemostasis in Glanzmann Thrombasthenia Patients: an in Vitro Study","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2023-04-06","conditions":"Glanzmann Thrombasthenia","enrollment":20},{"nctId":"NCT05675774","phase":"NA","title":"DECT for Differentiating Intracerebral Hemorrhage From Contrast Extravasation","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-10-17","conditions":"Stroke, Ischemic, Tomography, X-Ray Computed","enrollment":200},{"nctId":"NCT06152939","phase":"","title":"Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention or Thrombolytic Therapy","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-01-01","conditions":"Left Ventricular Thrombus","enrollment":400},{"nctId":"NCT05659160","phase":"","title":"Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2","status":"RECRUITING","sponsor":"Tianjin Huanhu Hospital","startDate":"2021-11-01","conditions":"Stroke, Acute Ischemic, Endovascular Procedures, Large Vessel Occlusion","enrollment":5000},{"nctId":"NCT04017039","phase":"NA","title":"Sleep, Blood Pressure and Vascular Health","status":"COMPLETED","sponsor":"University of Colorado, Boulder","startDate":"2016-11-10","conditions":"Blood Pressure, Sleep","enrollment":107},{"nctId":"NCT05885178","phase":"","title":"Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-1 (TRACK-LVO-1)","status":"UNKNOWN","sponsor":"Tianjin Huanhu Hospital","startDate":"2018-01-01","conditions":"Stroke, Acute Ischemic, Endovascular Procedures, Large Vessel Occlusion","enrollment":5000},{"nctId":"NCT06126367","phase":"","title":"Assessment of Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic Cardiovascular Disease/Aortic Valve Disease","status":"RECRUITING","sponsor":"East and North Hertfordshire NHS Trust","startDate":"2023-10-20","conditions":"Atherosclerosis, Aortic Valve Disease","enrollment":180},{"nctId":"NCT06124612","phase":"","title":"An Investigator-initiated Linked Study to OCEANIC-AF","status":"RECRUITING","sponsor":"East and North Hertfordshire NHS Trust","startDate":"2023-11-03","conditions":"Atrial Fibrillation","enrollment":100},{"nctId":"NCT06094569","phase":"","title":"Medical Imaging Screening for Posterior-circulation Ischemic Stroke","status":"RECRUITING","sponsor":"Tianjin Huanhu Hospital","startDate":"2019-06-01","conditions":"Endovascular Thrombectomy","enrollment":1000},{"nctId":"NCT06078995","phase":"","title":"Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China","status":"UNKNOWN","sponsor":"Huashan Hospital","startDate":"2023-04-02","conditions":"Ischemic Stroke","enrollment":1200},{"nctId":"NCT04732091","phase":"","title":"Therapeutic Use of Contrast Ultrasound in Acute Coronary Artery Disease","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2022-02-17","conditions":"Acute Myocardial Infarction, Unstable Angina","enrollment":540},{"nctId":"NCT04571580","phase":"PHASE3","title":"Effect of Low-dose Intracoronary Reteplase on Myocardial Infarct Size During Primary Percutaneous Coronary Intervention","status":"TERMINATED","sponsor":"Ge Junbo","startDate":"2021-07-01","conditions":"Acute ST-segment Elevation Myocardial Infarction","enrollment":36},{"nctId":"NCT04256473","phase":"PHASE2","title":"Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2019-08-10","conditions":"Ischemic Stroke","enrollment":200},{"nctId":"NCT01431326","phase":"","title":"Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care","status":"COMPLETED","sponsor":"Daniel Benjamin","startDate":"2011-11","conditions":"Adenovirus, Anesthesia, Anxiety","enrollment":3520},{"nctId":"NCT00178620","phase":"PHASE4","title":"Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2003-09","conditions":"Heart Disease, Myocardial Infarction, Acute Myocardial Infarction","enrollment":390},{"nctId":"NCT03620370","phase":"NA","title":"Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2018-08-12","conditions":"Stroke, Acute","enrollment":86},{"nctId":"NCT05005052","phase":"PHASE3","title":"Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities","status":"UNKNOWN","sponsor":"Value Outcomes Ltd.","startDate":"2021-11-25","conditions":"Chronic Venous Disease, Chronic Insufficiency Venous","enrollment":290},{"nctId":"NCT04159831","phase":"PHASE2","title":"A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions","status":"COMPLETED","sponsor":"Rein Therapeutics","startDate":"2020-09-26","conditions":"Pleural Effusion","enrollment":44},{"nctId":"NCT05764356","phase":"","title":"Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2023-03","conditions":"Novel Oral Anticoagulants, NOACs, Rivaroxaban","enrollment":2000},{"nctId":"NCT05188417","phase":"PHASE2","title":"A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"GrandPharma (China) Co., Ltd.","startDate":"2021-12-09","conditions":"Acute Ischemic Stroke","enrollment":266},{"nctId":"NCT03267199","phase":"","title":"The Relationship Between MPV,PDW,PFT and ST Segment Resolution in STEMI Patients Treated With Thrombolytic or Primary PCI","status":"WITHDRAWN","sponsor":"Assiut University","startDate":"2020-12","conditions":"STEMI - ST Elevation Myocardial Infarction","enrollment":""},{"nctId":"NCT02187120","phase":"PHASE3","title":"Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study)","status":"COMPLETED","sponsor":"Monash University","startDate":"2014-07-28","conditions":"Wounds and Injuries, Acute Coagulopathy","enrollment":1310},{"nctId":"NCT02964052","phase":"","title":"Selection Criteria in Endovascular Thrombectomy and Thrombolytic Therapy (SECRET) Study: Development of Patient Selection Criteria Using CT Images and Accompanying Diseases for Efficient Intravenous Thrombolytic and Intra-arterial Recanalization Therapy in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2016-11-18","conditions":"Ischemic Stroke","enrollment":1359},{"nctId":"NCT02398734","phase":"NA","title":"SONOlysis in Prevention of Brain InfaRctions During Internal Carotid Endarterectomy","status":"COMPLETED","sponsor":"University Hospital Ostrava","startDate":"2015-10","conditions":"Internal Carotid Artery Stenosis","enrollment":1492},{"nctId":"NCT03873766","phase":"PHASE4","title":"Management of Pleural Space Infections","status":"COMPLETED","sponsor":"Swedish Medical Center","startDate":"2019-04-01","conditions":"Empyema, Pleural, Parapneumonic Effusion","enrollment":26},{"nctId":"NCT02788344","phase":"","title":"Quality and Safety of Initial Management for ST-segment Elevation Myocardial Infarction","status":"COMPLETED","sponsor":"Centre Hospitalier Annecy Genevois","startDate":"2017-05-15","conditions":"Myocardial Infarction","enrollment":6920},{"nctId":"NCT04578288","phase":"NA","title":"Individualized Blood Pressure Management During Endovascular Stroke Treatment","status":"COMPLETED","sponsor":"University Hospital Heidelberg","startDate":"2020-10-01","conditions":"Acute Ischemic Stroke","enrollment":250},{"nctId":"NCT05493163","phase":"PHASE4","title":"Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism","status":"RECRUITING","sponsor":"Faculty Hospital Kralovske Vinohrady","startDate":"2022-10-19","conditions":"Pulmonary Embolism","enrollment":558},{"nctId":"NCT05258565","phase":"PHASE1","title":"TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients","status":"COMPLETED","sponsor":"Assiut University","startDate":"2022-03-01","conditions":"Acute Ischemic Stroke","enrollment":50},{"nctId":"NCT05598086","phase":"NA","title":"Anti-fibrinolytic and Anti-inflammatory Effects of Local Infiltration of Tranexamic Acid in Patients With Calcaneal Fractures","status":"COMPLETED","sponsor":"Hebei Medical University Third Hospital","startDate":"2019-04-01","conditions":"Tranexamic Acid, Fibrinolysis, Inflammatory","enrollment":113},{"nctId":"NCT00680628","phase":"PHASE3","title":"Clot Dissolving Treatment for Blood Clots in the Lungs","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2008-05","conditions":"Pulmonary Embolism","enrollment":83},{"nctId":"NCT01869413","phase":"PHASE2, PHASE3","title":"Tranexamic Acid During Cystectomy Trial (TACT)","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2013-06","conditions":"Bladder Cancer","enrollment":354},{"nctId":"NCT05534360","phase":"","title":"Tenecteplase Treatment in Ischemic Stroke Registry","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-09","conditions":"Stroke, Acute","enrollment":5000},{"nctId":"NCT04357899","phase":"","title":"Stroke Research Consortium in Northern Bavaria (STAMINA)","status":"COMPLETED","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2006-01-01","conditions":"Ischemic Stroke","enrollment":3769},{"nctId":"NCT04752631","phase":"PHASE4","title":"MRI-guided thrOmbolysis for Stroke bEyond Time Window by TNK","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2021-03-09","conditions":"Stroke","enrollment":80},{"nctId":"NCT02797119","phase":"PHASE4","title":"Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2016-03-15","conditions":"Pregnancy Complications, Hemorrhage","enrollment":225},{"nctId":"NCT03494920","phase":"PHASE3","title":"DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval","status":"COMPLETED","sponsor":"Neuroscience Trials Australia","startDate":"2018-04-27","conditions":"Ischemic Stroke","enrollment":295},{"nctId":"NCT05415150","phase":"PHASE1, PHASE2","title":"Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic","status":"UNKNOWN","sponsor":"Baylor College of Medicine","startDate":"2022-02-18","conditions":"Acute Ischemic Stroke","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2196,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Thrombolytic therapy","DNAse / tPA combination therapy."],"phase":"phase_3","status":"active","brandName":"Fibrinolytic therapy","genericName":"Fibrinolytic therapy","companyName":"All India Institute of Medical Sciences","companyId":"all-india-institute-of-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fibrinolytic therapy dissolves blood clots by activating plasminogen to plasmin, which breaks down fibrin and restores blood flow. Used for Acute myocardial infarction (ST-elevation MI), Acute ischemic stroke, Pulmonary embolism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}